EFFECT OF NON-HIV DRUGS ON NEUROCOGNITIVE DOMAINS IN A WELL-TREATED HIV POPULATION
Neurocognitive impairment (NCI) remains a problem in people with HIV (PWH) despite advances in HIV management. Medications with anticholinergic (ACH) activity have been associated with NCI in aging, HIV-negative persons. Previously we described ACH use in PWH >65 years old in the Swiss HIV Cohort Study (SHCS) and the association with self-reported NCI using SHCS screening questions…